Does ENZALUTAMIDE Cause Metastases to lymph nodes? 76 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Metastases to lymph nodes have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
76
Reports of Metastases to lymph nodes with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
2
Deaths
3
Hospitalizations
How Dangerous Is Metastases to lymph nodes From ENZALUTAMIDE?
Of the 76 reports, 2 (2.6%) resulted in death, 3 (3.9%) required hospitalization.
Is Metastases to lymph nodes Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Metastases to lymph nodes?
LETROZOLE (436)
DOCETAXEL (404)
CAPECITABINE (370)
PACLITAXEL (352)
TRASTUZUMAB (351)
FULVESTRANT (347)
CYCLOPHOSPHAMIDE (289)
RIBOCICLIB (276)
EVEROLIMUS (273)
TAMOXIFEN (244)
Which ENZALUTAMIDE Alternatives Have Lower Metastases to lymph nodes Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE